Structure and function of the von Willebrand factor A1 domain: Analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation

Blood

Volumn 95, Issue 1, 2000, Pages 164-172

  De Luca, Mariagrazia ^b   Facey, David A ^b   Favaloro, Emmanuel J ^b   Hertzberg, Mark S ^b   Whisstock, James C ^b   McNally, Tracy ^b   Andrews, Robert K ^a   Berndt, Michael C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; RISTOCETIN; SERUM AMYLOID P; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0033976060     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.164     Document Type: Article

References (35)

1. Weiss HJ. Flow-related platelet deposition on subendothelium. Thromb Haemostas. 1995;74: 117-122.
2. Kroll MH, Hellums JD, McIntyre LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525-1541.
3. Andrews RK, López JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol. 1997;29:91-105.
4. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature. 1979; 279: 635.
5. Sadler JE. von Willebrand factor. J Biol Chem. 1991;266:22,777-22,780.
6. Titani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry. 1986;25:3171-3184.
7. Fujimura Y, Titani K, Holland LZ, et al. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem. 1987;262:1734-1739.
8. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kd dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the α-chain of membrane glycoprotein Ib on intact platelets with bis (sulfosuccinimidyl) suberate. Biochemistry. 1989;28: 8326-8336.
9. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry. 1992;31:11,144-11,451.
10. Andrews RK, Booth WJ, Bendall LJ, Berndt MC. The amino acid sequence glutamine-628 to valine-646 within the A1 repeat domain mediates binding of von Willebrand factor to bovine brain sulfatides and equine tendon collagen. Platelets. 1995;6:245-251.
11. Roth GJ, Titani K, Hoyer LW, Mickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry. 1986;25:8357-8361.
12. Sobel M, Soler DF, Kermode JE, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem. 1992;267:8857-8862.
13. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. J Biol Chem. 1991;266: 18,172-18,178.
14. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemostas. 1990;64:326-332.
15. Azuma H, Sugimoto M, Ruggeri ZM, Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemostas. 1993;69: 192-196.
16. Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocerin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1989; 28:8317-8326.
17. De Luca M, Ward CM, Ohmori K, Andrews RK, Berndt MC. Jararhagin and jaracetin: novel snake venom inhibitors of the integrin collagen receptor, α2β1. Biochem Biophys Res Commun. 1995;206:570-576.
18. Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of the human platelet membrane glycoprotein Ib complex. Eur J Biochem. 1985;151: 637-649.
19. Berndt MC, Du X, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1988;27: 633-640.
20. Ruan C, Du X, Xi X, Castaldi PA, Berndt MC. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood. 1987;69:570-577.
21. Ward CM, Andrews HK, Smith Al, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ib α. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ib α as a binding site for von Willebrand factor and α-thrombin. Biochemistry. 1996;35:4929-4938.
22. Lerner RA, Green N, Alexander H, Liu F-T, Sutcliffe JG, Shinnick TM. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A. 1981;78: 3403-3407.
23. Booth WJ, Furby FH, Berndt MC, Castaldi PA. Factor VIII/von Willebrand factor has potent lectin activity. Biochem Biophys Res Commun. 1984; 118:495-501.
24. Andrews RK, Bendall LJ, Booth WJ, Berndt MC. Inhibition of binding of von Willebrand factor to the platelet glycoprotein Ib-IX complex, heparin and sulfatides by polyanionic compounds. The mechanism of modulation of the adhesive function of von Willebrand factor. Platelets. 1996;6: 252-258.
25. Emsley J, Cruz M, Handin R, Liddington R. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib. J Biol Chem. 1998;273:10,396-10,401.
26. Knott HM, Berndt MC, Kralicek AV, O'Donoghue SI, King, GF. Determination of the solution structure of a platelet adhesion peptide of von Willebrand factor. Biochemistry. 1992;31:11,152-11,158.
27. Matsushita T, Sadler JE. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. J Biol Chem. 1995;270:13,406-13,414.
28. Celikel R, Varughese KI, Madhusudan YA, Ware J, Ruggeri ZM. Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol. 1998;5: 189-194.
29. Nichols WC, Cooney KA, Ginsburg G, Ruggeri ZM. von Willebrand disease. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage. 2nd ed. Baltimore, MD: Williams & Wilkins; 1998: 729-755.
30. Weinstein M, Vosburgh E, Phillips M, Turner N, Chute-Rose L, Moake, J. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers. Blood. 1991;78:2291-2298.
31. Christophe O, Obert B, Meyer D, Girma J-P. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood 1991;78:2310-2317.
32. Girma J-P, Fressinaud E, Christophe O, et al. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulfide loop of von Willebrand factor and competing with glycoprotein Ib. Thromb Haemostas. 1992;68:707-713.
33. Dong J-F, Li CQ, López JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry. 1994;33:13,946-13,953.
34. Marchese P, Murata M, Mazzucato M, et al. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand Factor and α-thrombin binding. J Biol Chem. 1995;270: 9571-9578.
35. Nishio K, Fujimura Y, Nishida S, et al. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding. Haemostasis. 1991; 21:353-359.